13/01/2025
|
11:40
|
Notification of dealings by a director/PDMR
|
RNS
|
30/12/2024
|
07:00
|
Holding(s) in Company
|
RNS
|
19/12/2024
|
16:44
|
Notification of dealings by a director/PDMR
|
RNS
|
19/12/2024
|
07:00
|
New Development Contract
|
RNS
|
18/12/2024
|
10:53
|
TR-1: Standard form notification of major holdings
|
RNS
|
16/12/2024
|
11:28
|
Notification of dealings by a director/PDMR
|
RNS
|
12/12/2024
|
07:00
|
Holding(s) in Company
|
RNS
|
09/12/2024
|
15:30
|
Notification of dealings by a director/PDMR
|
RNS
|
09/12/2024
|
13:47
|
Notification of dealings by a director/PDMR
|
RNS
|
09/12/2024
|
07:00
|
Grant of Options and Director Fee Shares
|
RNS
|
06/12/2024
|
07:00
|
New Scientific Advisory Board Members
|
RNS
|
05/12/2024
|
07:00
|
Technical Update
|
RNS
|
29/11/2024
|
11:05
|
Results of 2024 Annual General Meeting
|
RNS
|
29/11/2024
|
07:00
|
AGM Statement
|
RNS
|
07/11/2024
|
07:00
|
Agreement extended with genetic medicines customer
|
RNS
|
06/11/2024
|
07:00
|
Commercial Trading Update
|
RNS
|
05/11/2024
|
07:00
|
Posting of Annual Report and Notice of AGM
|
RNS
|
22/10/2024
|
07:00
|
Full Year Results for the 12mths to 30 June 2024
|
RNS
|
17/10/2024
|
07:00
|
Notice of Results and Investor Presentation
|
RNS
|
16/09/2024
|
07:00
|
Director Appointment
|
RNS
|
03/09/2024
|
07:00
|
Aptamer extends contract with Unilever
|
RNS
|
27/08/2024
|
07:00
|
Block listing Interim Review
|
RNS
|
20/08/2024
|
14:26
|
Holding(s) in Company
|
RNS
|
16/08/2024
|
13:04
|
TR-1: Standard form notification of major holdings
|
RNS
|
14/08/2024
|
11:34
|
TR-1: Standard form notification of major holdings
|
RNS
|
13/08/2024
|
12:57
|
Result of General Meeting and Board Changes
|
RNS
|
01/08/2024
|
16:33
|
Supplementary Conditional Placing for £60,000
|
RNS
|
24/07/2024
|
18:11
|
Posting of Circular and Notice of General Meeting
|
RNS
|
24/07/2024
|
12:37
|
Fundraise to Raise £2.83 million
|
RNS
|
08/07/2024
|
07:05
|
Update on progress in Unilever partnership
|
RNS
|
08/07/2024
|
07:00
|
Trading Update
|
RNS
|
03/07/2024
|
07:00
|
Agreement to explore Optimer vehicles for siRNA
|
RNS
|
24/06/2024
|
07:00
|
New Contracts Announcement for Optimer Development
|
RNS
|
14/06/2024
|
07:00
|
Partnership with Microsaic Systems
|
RNS
|
31/05/2024
|
16:06
|
Holding(s) in Company
|
RNS
|
28/05/2024
|
09:05
|
Holding(s) in Company
|
RNS
|
23/05/2024
|
07:00
|
New contracts with top ten pharma partners
|
RNS
|
22/05/2024
|
07:00
|
Aptamer and Timser Partnership
|
RNS
|
13/05/2024
|
07:45
|
Trading Update
|
RNS
|
25/04/2024
|
15:45
|
Holding(s) in Company
|
RNS
|
24/04/2024
|
08:45
|
Holding(s) in Company
|
RNS
|
23/04/2024
|
14:03
|
Holding(s) in Company - REPLACEMENT
|
RNS
|
22/04/2024
|
16:37
|
Holding(s) in Company
|
RNS
|
22/04/2024
|
07:00
|
Top Pharma Company evaluates Optimer for medicine
|
RNS
|
18/04/2024
|
10:06
|
TR-1: Notification of major holdings
|
RNS
|
18/04/2024
|
07:00
|
Aptamer and Kairos Biotech partner for Optimer+
|
RNS
|
08/04/2024
|
07:00
|
Patent submission for Optimer® binders
|
RNS
|
28/03/2024
|
14:07
|
Holding(s) in Company
|
RNS
|
28/03/2024
|
07:00
|
Interim Results
|
RNS
|
22/03/2024
|
07:00
|
Notice of Interim Results & Investor Presentation
|
RNS
|